USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$12.47M
Market Cap
-
P/E Ratio
-1.68
EPS
$3.25
52 Week High
$1.62
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$372K |
Total Revenue | $58K |
Cost Of Revenue | $430K |
Costof Goods And Services Sold | $430K |
Operating Income | -$8M |
Selling General And Administrative | $3.7M |
Research And Development | $4.4M |
Operating Expenses | $7.6M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $67K |
Income Before Tax | -$7.9M |
Income Tax Expense | -$7.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.9M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8M |
Ebitda | -$7.9M |
Net Income | -$7.9M |
Field | Value (USD) |
---|---|
Total Assets | $3.7M |
Total Current Assets | $2.6M |
Cash And Cash Equivalents At Carrying Value | $2.4M |
Cash And Short Term Investments | $2.4M |
Inventory | - |
Current Net Receivables | $0 |
Total Non Current Assets | $1.1M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $251K |
Other Non Current Assets | - |
Total Liabilities | $2.9M |
Total Current Liabilities | $2.3M |
Current Accounts Payable | $385K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $770K |
Total Non Current Liabilities | $566K |
Capital Lease Obligations | $951K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $951K |
Other Current Liabilities | $634K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $837K |
Treasury Stock | - |
Retained Earnings | -$160M |
Common Stock | $5K |
Common Stock Shares Outstanding | $2.7M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$8M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $67K |
Capital Expenditures | $6K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$6K |
Cashflow From Financing | $9.3M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$7.9M |
Field | Value (USD) |
---|---|
Gross Profit | -$372K |
Total Revenue | $58K |
Cost Of Revenue | $430K |
Costof Goods And Services Sold | $430K |
Operating Income | -$8M |
Selling General And Administrative | $3.7M |
Research And Development | $4.4M |
Operating Expenses | $7.6M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $67K |
Income Before Tax | -$7.9M |
Income Tax Expense | -$7.9M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$7.9M |
Comprehensive Income Net Of Tax | - |
Ebit | -$8M |
Ebitda | -$7.9M |
Net Income | -$7.9M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.